•  
  •  
 

Saudi Toxicology Journal

Authors' ORCID

0000-0002-5725-3522

Keywords

Nosocomial infection, Antimicrobial resistance, Glasgow coma scale, Multidrug-resistant Gram-negative bacteria, Retrospective records

Document Type

Research Article

Abstract

Background: Hospital-acquired pneumonia (HAP) is an important healthcare-associated infection associated with morbidity, mortality, prolonged hospitalization, and antimicrobial use. Contemporary patient-level data from adult inpatients in Makkah remain limited.
Objectives: To estimate the prevalence of HAP and identify associated patient-related and hospital-related risk factors among adult inpatients in Makkah hospitals.
Methods: This retrospective cross-sectional medical-record study included 413 adult inpatients admitted to participating Makkah hospitals during 2022. HAP was defined as pneumonia occurring at least 48 hours after hospital admission and not present or incubating at admission. Demographic, clinical, hospital-exposure, and microbiological data were analyzed using descriptive and exploratory inferential methods. Because only 10 HAP events occurred, multivariable estimates were interpreted cautiously as hypothesis-generating.
Results: HAP was identified in 10 of 413 patients (2.4%; 95% CI, 1.3%-4.4%). Chronic lung disease and neurological disease showed strong unadjusted associations with HAP, but both produced complete separation because all HAP cases had these conditions. Higher BMI and lower Glasgow Coma Scale (GCS) scores were associated with HAP in unadjusted analyses. In the exploratory reduced multivariable model, lower GCS remained associated with HAP (adjusted OR 0.73 per point; 95% CI, 0.55-0.96), although the model is vulnerable to overfitting because only 10 events occurred. Gram-negative resistant organisms predominated among reported isolates.
Conclusion: In this 2022 hospital-record sample, HAP occurred in 2.4% of included patients. Chronic pulmonary and neurological disease were strongly associated with HAP in unadjusted analyses, but the small number of events limits reliable risk-factor estimation. The resistant Gram-negative organisms reported among HAP cases support continued infection-prevention and antimicrobial-stewardship efforts. Larger multicenter studies with complete exposure and microbiological data are needed.

Subject Area

Forensic and Analytical Toxicology

Acceptance Date

October 2026

Data Availability Statement

The data supporting the findings of this study are available from the corresponding author upon reasonable request.

Ethical Approval

Ethical approval was obtained from the Ministry of Health Institutional Review Board (approval number: H-02-K-067-1225-1507).

Article Publishing Charges USD 400

1

Share

COinS